用于心脏病预测的 XAI 增强投票集合模型:基于 SHAP 和 LIME 的方法

IF 3.8 3区 医学 Q2 ENGINEERING, BIOMEDICAL
Nermeen Gamal Rezk, Samah Alshathri, Amged Sayed, Ezz El-Din Hemdan, Heba El-Behery
{"title":"用于心脏病预测的 XAI 增强投票集合模型:基于 SHAP 和 LIME 的方法","authors":"Nermeen Gamal Rezk, Samah Alshathri, Amged Sayed, Ezz El-Din Hemdan, Heba El-Behery","doi":"10.3390/bioengineering11101016","DOIUrl":null,"url":null,"abstract":"<p><p>Ensemble Learning (EL) has been used for almost ten years to classify heart diseases, but it is still difficult to grasp how the \"black boxes\", or non-interpretable models, behave inside. Predicting heart disease is crucial to healthcare, since it allows for prompt diagnosis and treatment of the patient's true state. Nonetheless, it is still difficult to forecast illness with any degree of accuracy. In this study, we have suggested a framework for the prediction of heart disease based on Explainable artificial intelligence (XAI)-based hybrid Ensemble Learning (EL) models, such as LightBoost and XGBoost algorithms. The main goals are to build predictive models and apply SHAP (SHapley Additive expPlanations) and LIME (Local Interpretable Model-agnostic Explanations) analysis to improve the interpretability of the models. We carefully construct our systems and test different hybrid ensemble learning algorithms to determine which model is best for heart disease prediction (HDP). The approach promotes interpretability and transparency when examining these widespread health issues. By combining hybrid Ensemble learning models with XAI, the important factors and risk signals that underpin the co-occurrence of heart disease are made visible. The accuracy, precision, and recall of such models were used to evaluate their efficacy. This study highlights how crucial it is for healthcare models to be transparent and recommends the inclusion of XAI to improve interpretability and medical decisionmaking.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"11 10","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504639/pdf/","citationCount":"0","resultStr":"{\"title\":\"XAI-Augmented Voting Ensemble Models for Heart Disease Prediction: A SHAP and LIME-Based Approach.\",\"authors\":\"Nermeen Gamal Rezk, Samah Alshathri, Amged Sayed, Ezz El-Din Hemdan, Heba El-Behery\",\"doi\":\"10.3390/bioengineering11101016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Ensemble Learning (EL) has been used for almost ten years to classify heart diseases, but it is still difficult to grasp how the \\\"black boxes\\\", or non-interpretable models, behave inside. Predicting heart disease is crucial to healthcare, since it allows for prompt diagnosis and treatment of the patient's true state. Nonetheless, it is still difficult to forecast illness with any degree of accuracy. In this study, we have suggested a framework for the prediction of heart disease based on Explainable artificial intelligence (XAI)-based hybrid Ensemble Learning (EL) models, such as LightBoost and XGBoost algorithms. The main goals are to build predictive models and apply SHAP (SHapley Additive expPlanations) and LIME (Local Interpretable Model-agnostic Explanations) analysis to improve the interpretability of the models. We carefully construct our systems and test different hybrid ensemble learning algorithms to determine which model is best for heart disease prediction (HDP). The approach promotes interpretability and transparency when examining these widespread health issues. By combining hybrid Ensemble learning models with XAI, the important factors and risk signals that underpin the co-occurrence of heart disease are made visible. The accuracy, precision, and recall of such models were used to evaluate their efficacy. This study highlights how crucial it is for healthcare models to be transparent and recommends the inclusion of XAI to improve interpretability and medical decisionmaking.</p>\",\"PeriodicalId\":8874,\"journal\":{\"name\":\"Bioengineering\",\"volume\":\"11 10\",\"pages\":\"\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2024-10-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504639/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioengineering\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3390/bioengineering11101016\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering11101016","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

摘要

集合学习(EL)用于心脏病分类已有近十年的历史,但要掌握 "黑盒子"(即无法解读的模型)内部的行为方式仍然十分困难。预测心脏病对医疗保健至关重要,因为它可以及时诊断和治疗病人的真实情况。然而,要准确预测疾病仍有一定难度。在这项研究中,我们提出了一个基于可解释人工智能(XAI)的混合集合学习(EL)模型(如 LightBoost 和 XGBoost 算法)的心脏病预测框架。主要目标是建立预测模型,并应用 SHAP(SHapley Additive ExpPlanations)和 LIME(Local Interpretable Model-agnostic Explanations)分析来提高模型的可解释性。我们精心构建了我们的系统,并测试了不同的混合集合学习算法,以确定哪种模型最适合心脏病预测(HDP)。在研究这些普遍存在的健康问题时,这种方法提高了可解释性和透明度。通过将混合集合学习模型与 XAI 相结合,支撑心脏病共同发生的重要因素和风险信号变得清晰可见。这些模型的准确度、精确度和召回率被用来评估其功效。这项研究强调了医疗模型透明化的重要性,并建议将 XAI 纳入其中,以提高可解释性和医疗决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
XAI-Augmented Voting Ensemble Models for Heart Disease Prediction: A SHAP and LIME-Based Approach.

Ensemble Learning (EL) has been used for almost ten years to classify heart diseases, but it is still difficult to grasp how the "black boxes", or non-interpretable models, behave inside. Predicting heart disease is crucial to healthcare, since it allows for prompt diagnosis and treatment of the patient's true state. Nonetheless, it is still difficult to forecast illness with any degree of accuracy. In this study, we have suggested a framework for the prediction of heart disease based on Explainable artificial intelligence (XAI)-based hybrid Ensemble Learning (EL) models, such as LightBoost and XGBoost algorithms. The main goals are to build predictive models and apply SHAP (SHapley Additive expPlanations) and LIME (Local Interpretable Model-agnostic Explanations) analysis to improve the interpretability of the models. We carefully construct our systems and test different hybrid ensemble learning algorithms to determine which model is best for heart disease prediction (HDP). The approach promotes interpretability and transparency when examining these widespread health issues. By combining hybrid Ensemble learning models with XAI, the important factors and risk signals that underpin the co-occurrence of heart disease are made visible. The accuracy, precision, and recall of such models were used to evaluate their efficacy. This study highlights how crucial it is for healthcare models to be transparent and recommends the inclusion of XAI to improve interpretability and medical decisionmaking.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Bioengineering
Bioengineering Chemical Engineering-Bioengineering
CiteScore
4.00
自引率
8.70%
发文量
661
期刊介绍: Aims Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal: ● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings. ● Manuscripts regarding research proposals and research ideas will be particularly welcomed. ● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material. ● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds. Scope ● Bionics and biological cybernetics: implantology; bio–abio interfaces ● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices ● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc. ● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology ● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering ● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation ● Translational bioengineering
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信